Back
Campbell Soup 10K Form
Buy
65
CPB
Campbell Soup
Last Price:
51.91
Seasonality Move:
5.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-06-05 | 10Q | CPB/Campbell Soup Quarterly |
| 2024-03-06 | 10Q | CPB/Campbell Soup Quarterly |
| 2023-12-06 | 10Q | CPB/Campbell Soup Quarterly |
| 2023-09-21 | 10K | CPB/Campbell Soup Annual |
| 2023-06-07 | 10Q | CPB/Campbell Soup Quarterly |
| 2023-03-08 | 10Q | CPB/Campbell Soup Quarterly |
Receive CPB News And Ratings
See the #1 stock for the next 7 days that we like better than CPB
CPB Financial Statistics
Sales & Book Value
| Annual Sales: | $9.64B |
|---|---|
| Cash Flow: | $147M |
| Price / Cash Flow: | 23.23 |
| Annual Sales: | $12.71 |
| Price / Book: | 4.08 |
Profitability
| EPS (TTM): | 1.89000 |
|---|---|
| Net Income (TTM): | $567M |
| Gross Margin: | $2.97B |
| Return on Equity: | 14.94% |
| Return on Assets: | 4.24% |
Campbell Soup Earnings Forecast
Key Campbell Soup Financial Ratios
- The Gross Profit Margin over the past 41 years for CPB is 30.83%.
- The Selling, General & Administrative Expenses for CPB have been equal to 16.29% of Gross Profit Margin.
- The Research & Development expenses have been 1.06% of Revenue.
- The Interest Expense is 42.86% of Operating Income.
- The Net Earning history of CPB is 5.88% of Total Revenues.
- Per Share Earnings over the last 41 years have been positive in 21 years.
Campbell Soup Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Food Products |
| Sector: | Consumer Staples |
| Current Symbol: | CPB |
| CUSIP: | 134429 |
| Website: | campbellsoupcompany.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0.61 |
| Quick Ratio: | 0.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 27.46 |
|---|---|
| Forward P/E Ratio: | 15.27 |
CPB Technical Analysis vs Fundamental Analysis
Buy
65
Campbell Soup (CPB)
is a Buy
Is Campbell Soup a Buy or a Sell?
-
Campbell Soup stock is rated a Buy
The current Campbell Soup [CPB] share price is $51.90. The Score for CPB is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.